Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin vs olfactory training vs placebo for smell function in CKD and diabetes
IRCT20181001041190N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of curcumin in chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM) and Olfactory disorder (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Change in olfactory function. Started Aug 2021; status: completed.
02
Drugs
curcumin
03
Conditions
chronic kidney disease (CKD)type 2 diabetes mellitus (T2DM)Olfactory disorder
Beyond the preview
Go deeper on IRCT20181001041190N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181001041190N2.